1-3 of 3
Mohamed I. Farhat, MD
Close
Sort by
Journal Articles

Incorporating Target Immunotherapy into Standard Conditioning Regimen Prior to Autologous Stem Cell Transplantaion (ASCT) Improves the Transplant Outcome for Pateints with Relapsed/Refractroy B Cell Non-Hodgkin Lymphoma (B-NHL).

Mohamed I. Farhat, MD, Reem Karmali, MD, Stephanie A. Gregory, MD, Parameswaran Venugopal, MD, Mohamad Kassar, MD, Neel Shah, MD, Terrance Brooks, Henry C. Fung, MD
Journal: Blood
Blood (2007) 110 (11): 1911.
https://doi.org/10.1182/blood.V110.11.1911.1911
Published: 2007
Journal Articles

Autologous (Auto) and Allogeneic (Allo) Stem Cell Transplantation (SCT) for Pateints (pts) with Advanced Chronic Lymphoctic Leukemia (CLL): A Comparative Study.

Antonio Jimenez, MD, Mohamed I. Farhat, MD, Stephanie A. Gregory, MD, Mohamad Kassar, MD, Alla Gimelfarb, MD, Marta Batus, MD, Julie Nangia, MD, Neel Shah, MD, Parameswaran Venugopal, MD, Melissa L. Larson, MD, Kent W. Christopherson, PHD, Henry C. Fung, MD
Journal: Blood
Blood (2007) 110 (11): 5044.
https://doi.org/10.1182/blood.V110.11.5044.5044
Published: 2007
Journal Articles

Hematopoietic Cell Transplantation - Comorbidity Index (HCT-CI) as a Surrgoate Marker for Predition of Transplant Outcome for Pateints (pts) with Multiple Myeloma (MM) Undergoing Autologous Stem Cell Transplantation (ASCT): High HCT-CI Score Predicts for Poor Outcome.

Mohamed I. Farhat, MD, Ronald Myint, MD, Stephanie A. Gregory, MD, Parameswaran Venugopal, MD, Mohamad Kassar, MD, Alla Gimelfarb, MD, Marta Batus, MD, Julie Nangia, MD, John Maciejewski, MD, Amanda Law, NP, Henry C. Fung, MD
Journal: Blood
Blood (2007) 110 (11): 5104.
https://doi.org/10.1182/blood.V110.11.5104.5104
Published: 2007